19Mar/23
Knockdown of Two Genes by CRISPR-Cas9 to Improve T-Cell Therapy in Solid Tumors
Since the world’s first chimeric antigen receptor (CAR)-T cell therapy was approved for marketing in 2017, the Food and Drug Administration (FDA) has approved a total of six CAR-T cell therapies toRead More…